InvestSMART

Cochlear Limited (ASX: COH) - Announcements

- Current share price for COH : $128.720

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8,418 HY23 Result - Presentation Slides 15 Feb 2023 8:12AM $209.080 $128.720 fallen by 38.44%
$8,418 HY23 Result - ASX & Media Release 15 Feb 2023 8:10AM $209.080 $128.720 fallen by 38.44%
$8,418 Dividend/Distribution - COH 15 Feb 2023 8:09AM $209.080 $128.720 fallen by 38.44%
$8,418 Appendix 4D and Half Year Financial Report 15 Feb 2023 8:09AM $209.080 $128.720 fallen by 38.44%
$8,418 Application for quotation of securities - COH 30 Jan 2023 4:24PM $208.770 $128.720 fallen by 38.34%
$8,418 Notice of HY23 result analyst and media briefing 24 Jan 2023 4:15PM $203.410 $128.720 fallen by 36.72%
$8,418 Notification of cessation of securities - COH 12 Jan 2023 12:16PM $207.040 $128.720 fallen by 37.83%
$8,418 Oticon Medical acquisition - UK CMA decision 7 Dec 2022 9:03AM $211.910 $128.720 fallen by 39.26%
$8,418 Acquisition of Oticon Medical-ACCC Statement 1 Dec 2022 10:07AM $212.030 $128.720 fallen by 39.29%
$8,418 AXX: Preliminary concerns Cochlear Oticon proposed acquisiti 1 Dec 2022 9:13AM $214.040 $128.720 fallen by 39.86%
$8,418 Notification regarding unquoted securities - COH 3 Nov 2022 10:57AM $193.920 $128.720 fallen by 33.62%
$8,418 Appendix 3Y - Michael del Prado 2 Nov 2022 11:54AM $202.130 $128.720 fallen by 36.32%
$8,418 Appendix 3Y - Alison Deans 31 Oct 2022 9:33AM $197.080 $128.720 fallen by 34.69%
$8,418 Appendix 3Y - Bruce Robinson 28 Oct 2022 10:45AM $197.465 $128.720 fallen by 34.81%
$8,418 Application for quotation of securities - COH 26 Oct 2022 8:48AM $196.080 $128.720 fallen by 34.35%
$8,418 Appendix 3Y - Karen Penrose 24 Oct 2022 9:02AM $193.290 $128.720 fallen by 33.41%
$8,418 Application for quotation of securities - COH 24 Oct 2022 8:41AM $193.290 $128.720 fallen by 33.41%
$8,418 Appendix 3Y - Diggory Howitt 20 Oct 2022 4:25PM $194.800 $128.720 fallen by 33.92%
$8,418 Notification regarding unquoted securities - COH 20 Oct 2022 12:28PM $195.830 $128.720 fallen by 34.27%
$8,418 2022 AGM Results 18 Oct 2022 2:14PM $197.740 $128.720 fallen by 34.90%
$8,418 2022 AGM Chair and CEO & President Addresses 18 Oct 2022 8:41AM $193.630 $128.720 fallen by 33.52%
$8,418 Notification of cessation of securities - COH 12 Oct 2022 2:48PM $190.430 $128.720 fallen by 32.41%
$8,418 Appendix 3Y - Diggory Howitt 6 Oct 2022 9:50AM $206.670 $128.720 fallen by 37.72%
$8,418 Notification regarding unquoted securities - COH 6 Oct 2022 9:45AM $206.670 $128.720 fallen by 37.72%
$8,418 Update - Dividend/Distribution - COH 4 Oct 2022 9:55AM $195.000 $128.720 fallen by 33.99%

401 - 425 of 944 results

Page 17 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.